|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Van Naarden Jacob | EVP & Pres., Lilly Oncology | Aug 13 '25 | Buy | 647.36 | 1,000 | 647,360 | 20,562 | Aug 13 04:15 PM |
| LLY | Van Naarden Jacob | EVP & Pres., Lilly Oncology | Feb 01 '25 | Option Exercise | 0.00 | 3,023 | 0 | 14,868 | Feb 04 04:26 PM |
| LLY | Van Naarden Jacob | EVP & Pres., Loxo@Lilly | Feb 01 '24 | Option Exercise | 0.00 | 3,618 | 0 | 15,463 | Feb 02 04:22 PM |
| LLY | Van Naarden Jacob | EVP and CEO Loxo@Lilly | Feb 16 '23 | Option Exercise | 0.00 | 2,785 | 0 | 13,159 | Feb 21 04:35 PM |
| LLY | Van Naarden Jacob | SVP, CEO LoxoONC, Pres LlyONC | Feb 16 '22 | Option Exercise | 0.00 | 5,461 | 0 | 10,153 | Feb 17 04:44 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite